This Sources Sought opportunity from Department Of Veterans Affairs was posted on May 1, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Blood Sample Protein Measurement Analysis
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Washington DC VA Medical Center is seeking vendor capabilities to perform high-plex proteomic analysis on approximately 120 coded frozen plasma samples from 24 Veterans with advanced metastatic prostate cancer, aiming to identify circulating protein signatures linked to treatment response and disease progression. The work will be conducted under a Firm Fixed Price contract at the vendor’s CLIA-certified facility using the SomaScan® Assay Platform, version 4.1 or later, with all samples shipped and maintained at -80°C throughout transit and processing. Deliverables include proteomic data in standard ADAT format, a PDF assay quality statement, and the return of any unused biological samples to the VA at 50 Irving St., Washington, DC 20422, all of which are U.S. Government property. The contract includes a base year with a one-year option and requires strict adherence to VA data handling protocols under the Privacy Act, FOIA, NARA, and NIST guidelines, including prohibitions against co-mingling VA data with non-VA information and mandatory destruction or return of data upon contract termination with written certification. Vendors must provide their Unique Entity Identifier, disclose their small business or socioeconomic status, and demonstrate experience with CLIA-certified proteomic workflows and cold chain logistics; however, no evaluation weights, scoring criteria, or award methodology are specified as this is a sources-sought notice for market research. All submissions must be sent via email to Veronica Dillard by 3:00 PM EDT on May 15, 2026, and include business information, a capability statement, past performance details, and quality assurance documentation in standard electronic formats such as PDF or DOCX, with no formal page limits imposed.
General Info
Agency
NAICS
Place of Performance
Washington, DC, 20422, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
The Washington DC VA Medical Center (DC VAMC) is conducting a prospective biospecimen collection and clinical data repository study. Advanced prostate cancer remains a leading cause of cancer morbidity and mortality among Veterans, yet validated circulating biomarkers that predict treatment response or early disease progression are lacking. Current clinical decision-making relies primarily on PSA kinetics and radiographic imaging, which have well-recognized limitations in sensitivity and lead time. The goal of the research study is to generate reproducible, high-quality proteomic data from the study’s longitudinal plasma specimens so that the VA study team can conduct exploratory analyses linking circulating proteomic changes to clinical outcomes, ultimately informing future biomarker validation studies and precision oncology strategies for Veterans with advanced prostate cancer.
More opportunities from Department Of Veterans Affairs → 245-NETWORK Contract Office 5 (36C245)
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
